| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1086/519471 |
| P698 | PubMed publication ID | 17712745 |
| P2093 | author name string | Scott T Micek | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Staphylococcus aureus | Q188121 |
| vancomycin | Q424027 | ||
| methicillin-resistant Staphylococcus aureus | Q595158 | ||
| P304 | page(s) | S184-90 | |
| P577 | publication date | 2007-09-01 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections | |
| P478 | volume | 45 Suppl 3 |
| Q36744836 | Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus |
| Q90459167 | Adjunctive rifampin for the treatment of Staphylococcus aureus bacteremia with deep infections: A meta-analysis |
| Q37112508 | Advances in MRSA drug discovery: where are we and where do we need to be? |
| Q30238945 | Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation |
| Q35223557 | Antibiotic-loaded chitosan film for infection prevention: A preliminary in vitro characterization |
| Q36017541 | Antimicrobial Effects and Resistant Regulation of Magnolol and Honokiol on Methicillin-Resistant Staphylococcus aureus |
| Q54318620 | Antimicrobial and anti-inflammatory properties of Funtumia elastica. |
| Q38690166 | Bacteriostatic antimicrobial combination: antagonistic interaction between epsilon-viniferin and vancomycin against methicillin-resistant Staphylococcus aureus |
| Q30009348 | Biochemical and biophysical characterization of PlyGRCS, a bacteriophage endolysin active against methicillin-resistant Staphylococcus aureus |
| Q42027484 | Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus |
| Q43993247 | Ceftobiprole medocaril is an effective treatment against methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis in a rat model |
| Q37762092 | Ceftobiprole: A novel, broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus |
| Q37593094 | Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections |
| Q40337018 | Cellulitis caused by a methicillin-sensitive Staphylococcus aureus isolate harboring Panton-Valentine toxin in an American soldier returning from Iraq |
| Q92546679 | Clinical practice guidelines for the provision of renal service in Hong Kong: Infection Control in Renal Service |
| Q38051319 | Community-Associated Methicillin-Resistant Staphylococcus aureus in the Pediatric Population |
| Q36438720 | Community-associated meticillin-resistant Staphylococcus aureus |
| Q35026521 | Current and novel antibiotics against resistant Gram-positive bacteria |
| Q37291338 | Current challenges in treating MRSA: what are the options? |
| Q37853607 | Cutaneous community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus |
| Q44738071 | Daptomycin for the treatment of gram-positive infections after cardiac surgery |
| Q37150644 | Daptomycin for the treatment of major gram-positive infections after cardiac surgery. |
| Q35026595 | Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens |
| Q58762088 | Effects of pharmacist intervention in Vancomycin treatment for patients with bacteremia due to Methicillin-resistant Staphylococcus aureus |
| Q38121142 | Emerging drugs on methicillin-resistant Staphylococcus aureus |
| Q51554806 | Genotypes, antibiotic resistance profiles and microarray-based characterization of methicillin-resistant Staphylococcus aureus strains isolated from livestock and veterinarians in Switzerland. |
| Q36894894 | High frequency of methicillin-resistant Staphylococcus aureus in Peshawar Region of Pakistan |
| Q43048123 | Hospital policies and practices on prevention and treatment of infections caused by methicillin-resistant Staphylococcus aureus |
| Q34955858 | Iclaprim: a novel dihydrofolate reductase inhibitor for skin and soft tissue infections |
| Q40529090 | Identification of 5,6-dihydroimidazo[2,1-b]thiazoles as a new class of antimicrobial agents. |
| Q33822841 | Identification of tigecycline- and vancomycin-resistant Staphylococcus aureus strains among patients with urinary tract infection in Iran. |
| Q33461682 | In vitro activity of daptomycin against Staphylococci isolated from bacteremia and community-onset skin and soft tissue infections in France: data from two nationwide studies. |
| Q36018796 | In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogens |
| Q55282270 | In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus. |
| Q33736172 | In vitro synergistic effect of curcumin in combination with third generation cephalosporins against bacteria associated with infectious diarrhea |
| Q34664160 | Management of febrile neutropenia in the era of bacterial resistance |
| Q90094051 | Minimum Inhibitory Concentrations of Vancomycin and Daptomycin Against Methicillin-resistant Staphylococcus Aureus Isolated from Various Clinical Specimens: A Study from South India |
| Q37247772 | Multicenter, randomized study of the efficacy and safety of intravenous iclaprim in complicated skin and skin structure infections |
| Q37533556 | New antibiotics for the management of complicated skin and soft tissue infections: are they any better? |
| Q43281628 | New antibiotics: small or big advances? |
| Q37537353 | New antimicrobial agents for the treatment of bacterial infections in cancer patients |
| Q37329167 | New trends in pharmacogenomic strategies against resistance development in microbial infections |
| Q35785093 | No Outbreak of Vancomycin and Linezolid Resistance in Staphylococcal Pneumonia over a 10-Year Period |
| Q91742543 | Novel antibiotics effective against gram-positive and -negative multi-resistant bacteria with limited resistance |
| Q39933945 | Novel antibiotics for the treatment of Staphylococcus aureus |
| Q37071199 | Oritavancin: a new promising agent in the treatment of infections due to Gram-positive pathogens. |
| Q33726692 | Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers. |
| Q91650104 | Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus |
| Q33704733 | Real-time PCR testing for mecA reduces vancomycin usage and length of hospitalization for patients infected with methicillin-sensitive staphylococci |
| Q34975860 | Reduced susceptibility to vancomycin and biofilm formation in methicillin-resistant Staphylococcus epidermidis isolated from blood cultures. |
| Q37225677 | Resistance profiles in surgical-site infection |
| Q35619094 | Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era |
| Q35910257 | Retrospective Analysis of Clinical and Cost Outcomes Associated with Methicillin-Resistant Staphylococcus aureus Complicated Skin and Skin Structure Infections Treated with Daptomycin, Vancomycin, or Linezolid |
| Q43378543 | Review on Usage of Vancomycin in Livestock and Humans: Maintaining Its Efficacy, Prevention of Resistance and Alternative Therapy. |
| Q44340623 | Statistical optimization of a multivariate fermentation process for enhancing antibiotic activity of Streptomyces sp. CS392. |
| Q36243256 | Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA. |
| Q93160577 | The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase-negative staphylococci strains: a systematic review and meta-analysis |
| Q54326061 | Therapy of 1,025 severely ill patients with complicated infections in a German multicenter study: safety profile and efficacy of tigecycline in different treatment modalities. |
| Q36405066 | Therapy-refractory Panton Valentine Leukocidin-positive community-acquired methicillin-sensitive Staphylococcus aureus sepsis with progressive metastatic soft tissue infection: a case report |
| Q38089193 | Update on carbohydrate-containing antibacterial agents |
| Q37365775 | What's new on the antimicrobial horizon? |
| Q37533542 | Why is community-associated MRSA spreading across the world and how will it change clinical practice? |
| Q35097174 | Wound healing activity and mechanisms of action of an antibacterial protein from the venom of the eastern diamondback rattlesnake (Crotalus adamanteus) |
| Q84028199 | [Daptomycin therapy in patients with bacteremia] |
Search more.